Maravai LifeSciences Holdings, Inc. (MRVI) vs Zymeworks Inc. (ZYME)
- Maravai LifeSciences Holdings, Inc. MRVI 6.79 −3.96%
- Zymeworks Inc. ZYME 25.07 −2.64%
Maravai LifeSciences Holdings, Inc. and Zymeworks Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Zymeworks Inc. are of similar size ($1.8B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −69.8%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −404.0%) and the lower return on invested capital (−15.8% vs 0.00%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Zymeworks Inc. on 5.
Valuation
Profitability
| Metric | MRVI | ZYME | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | (246.66%) | 65.16% |
| Operating margin | (56.08%) | (418.99%) | 0.00% |
| Net margin | (37.07%) | (404.00%) | 0.00% |
| Free cash flow margin | (17.17%) | (324.68%) | 0.00% |
| Return on equity | (18.79%) | (72.31%) | (56.36%) |
| Return on assets | (10.31%) | (37.25%) | (48.04%) |
| Return on invested capital | (15.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack